OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exploring the target scope of KEAP1 E3 ligase-based PROTACs
Guangyan Du, Jie Jiang, Nathaniel J. Henning, et al.
Cell chemical biology (2022) Vol. 29, Iss. 10, pp. 1470-1481.e31
Open Access | Times Cited: 53
Guangyan Du, Jie Jiang, Nathaniel J. Henning, et al.
Cell chemical biology (2022) Vol. 29, Iss. 10, pp. 1470-1481.e31
Open Access | Times Cited: 53
Showing 26-50 of 53 citing articles:
Workflow for E3 Ligase Ligand Validation for PROTAC Development
Nebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
ACS Chemical Biology (2025)
Open Access
Nebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
ACS Chemical Biology (2025)
Open Access
A Keap1-recruiting BRD4 Degrader Offers a Single-molecular Polypharmacology Approach for the Treatment of Metabolic Dysfunction-associated Steatohepatitis
Xian Zhang, Yuxin Ge, Mengjie Ye, et al.
Free Radical Biology and Medicine (2025) Vol. 232, pp. 15-27
Closed Access
Xian Zhang, Yuxin Ge, Mengjie Ye, et al.
Free Radical Biology and Medicine (2025) Vol. 232, pp. 15-27
Closed Access
Targeted protein degradation for cancer therapy
Matthias Hinterndorfer, Valentina A. Spiteri, Alessio Ciulli, et al.
Nature reviews. Cancer (2025)
Closed Access
Matthias Hinterndorfer, Valentina A. Spiteri, Alessio Ciulli, et al.
Nature reviews. Cancer (2025)
Closed Access
Drug discovery technologies–Current and future trends
Mark C. Noe, Claire M. Steppan, Andrea D. Weston
Elsevier eBooks (2025)
Closed Access
Mark C. Noe, Claire M. Steppan, Andrea D. Weston
Elsevier eBooks (2025)
Closed Access
Targeted Protein Degradation: Design Considerations for PROTAC Development
Nathan L. Tran, Georges A. Leconte, Fleur M. Ferguson
Current Protocols (2022) Vol. 2, Iss. 12
Open Access | Times Cited: 18
Nathan L. Tran, Georges A. Leconte, Fleur M. Ferguson
Current Protocols (2022) Vol. 2, Iss. 12
Open Access | Times Cited: 18
Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2
Daniel C. Scott, Suresh Dharuman, Elizabeth C. Griffith, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Daniel C. Scott, Suresh Dharuman, Elizabeth C. Griffith, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
A Degron Blocking Strategy Towards Improved CRL4CRBN Recruiting PROTAC Selectivity**
Habib Bouguenina, Andrea Scarpino, Jack A. O’Hanlon, et al.
ChemBioChem (2023) Vol. 24, Iss. 23
Open Access | Times Cited: 9
Habib Bouguenina, Andrea Scarpino, Jack A. O’Hanlon, et al.
ChemBioChem (2023) Vol. 24, Iss. 23
Open Access | Times Cited: 9
Crystallization of VHL-based PROTAC-induced ternary complexes
Andre Wijaya, William Farnaby, Alessio Ciulli
Methods in enzymology on CD-ROM/Methods in enzymology (2023), pp. 241-263
Closed Access | Times Cited: 8
Andre Wijaya, William Farnaby, Alessio Ciulli
Methods in enzymology on CD-ROM/Methods in enzymology (2023), pp. 241-263
Closed Access | Times Cited: 8
HiBiT-SpyTag: A Minimal Tag for Covalent Protein Capture and Degrader Development
Tiffany Tsang, Fidel Huerta, Yingpeng Liu, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 933-941
Closed Access | Times Cited: 8
Tiffany Tsang, Fidel Huerta, Yingpeng Liu, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 933-941
Closed Access | Times Cited: 8
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity
Eriko Koide, Mikaela L. Mohardt, Zainab M. Doctor, et al.
ChemBioChem (2023) Vol. 24, Iss. 19
Closed Access | Times Cited: 8
Eriko Koide, Mikaela L. Mohardt, Zainab M. Doctor, et al.
ChemBioChem (2023) Vol. 24, Iss. 19
Closed Access | Times Cited: 8
Targeted Protein Degradation through Recruitment of the CUL4A Complex Adaptor Protein DDB1
Margot Meyers, Sabine Cismoski, Anoohya Panidapu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Margot Meyers, Sabine Cismoski, Anoohya Panidapu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Heterobifunctional Ligase Recruiters Enable pan-Degradation of Inhibitor of Apoptosis Proteins
Yuen Lam Dora Ng, Aleša Bricelj, Jacqueline A. Jansen, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4703-4733
Open Access | Times Cited: 5
Yuen Lam Dora Ng, Aleša Bricelj, Jacqueline A. Jansen, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4703-4733
Open Access | Times Cited: 5
Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response
Mengchen Lu, Jianai Ji, Yifei Lv, et al.
Cell chemical biology (2023) Vol. 31, Iss. 6, pp. 1188-1202.e10
Closed Access | Times Cited: 5
Mengchen Lu, Jianai Ji, Yifei Lv, et al.
Cell chemical biology (2023) Vol. 31, Iss. 6, pp. 1188-1202.e10
Closed Access | Times Cited: 5
Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues
Marta Pichlak, Tomasz Sobierajski, K. M. Błażewska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Marta Pichlak, Tomasz Sobierajski, K. M. Błażewska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Exploiting the Cullin E3 Ligase Adaptor Protein SKP1 for Targeted Protein Degradation
Seong Ho Hong, Akane Osa, Oscar W. Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Seong Ho Hong, Akane Osa, Oscar W. Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Discovery of Alkenyl Oxindole as a Novel PROTAC Moiety for Targeted Protein Degradation via CRL4DCAF11Recruitment
Ying Wanga, Tianzi Wei, Man Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Ying Wanga, Tianzi Wei, Man Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders
Melissa Lim, Thang Do Cong, Lauren M. Orr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Melissa Lim, Thang Do Cong, Lauren M. Orr, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions
Linjie Li, Song Liu, Youfu Luo
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116394-116394
Closed Access | Times Cited: 1
Linjie Li, Song Liu, Youfu Luo
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116394-116394
Closed Access | Times Cited: 1
A double whammy for KEAP1
Jan Gerhartz, Radosław P. Nowak
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1047-1049
Closed Access | Times Cited: 1
Jan Gerhartz, Radosław P. Nowak
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1047-1049
Closed Access | Times Cited: 1
Current Challenges in Small Molecule Proximity-Inducing Compound Development for Targeted Protein Degradation Using the Ubiquitin Proteasomal System
R. Sridhar, Oskar Hoff, Markus K. Muellner
Molecules (2022) Vol. 27, Iss. 23, pp. 8119-8119
Open Access | Times Cited: 7
R. Sridhar, Oskar Hoff, Markus K. Muellner
Molecules (2022) Vol. 27, Iss. 23, pp. 8119-8119
Open Access | Times Cited: 7
Investigation of the ubiquitin proteasome system in pulmonary arterial hypertension
Yu Li, Mianli Bian, Shujun Gu, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 2
Yu Li, Mianli Bian, Shujun Gu, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 2
Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development
Mark S. Cooper, Mark C. Norley, S Armitage, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 41, pp. 8344-8352
Closed Access | Times Cited: 2
Mark S. Cooper, Mark C. Norley, S Armitage, et al.
Organic & Biomolecular Chemistry (2023) Vol. 21, Iss. 41, pp. 8344-8352
Closed Access | Times Cited: 2
Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12
Andrew J. Ingersoll, Devlon M. McCloud, Jane Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Andrew J. Ingersoll, Devlon M. McCloud, Jane Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cyclic vinyl sulfones activate NRF2 to protect from oxidative stress-induced programmed necrosis
Pavel B. Davidovich, D. N. Nikolaev, Raniya Khadiullina, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130058-130058
Closed Access
Pavel B. Davidovich, D. N. Nikolaev, Raniya Khadiullina, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130058-130058
Closed Access
